Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q1 2024 Earnings Call Transcript May 14, 2024
Cellectar Biosciences, Inc. misses on earnings expectations. Reported EPS is $-0.74 EPS, expectations were $-0.5.
Operator: Good morning and welcome to Cellectar Biosciences First Quarter 2024 Earnings Call. Today’s call is being recorded. Before we begin, I would like to remind everyone that statements made during this call relating to Cellectar’s expected future performance, future business prospects...
